These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7967896)
21. [Antithrombotic drugs in the acute coronary syndrome]. Jareño Chaumel A; Cercas Sánchez A Rev Clin Esp; 1996 Dec; 196(4 Monografico):26-38. PubMed ID: 9139329 [No Abstract] [Full Text] [Related]
22. Unresolved issues in the prevention and treatment of venous thromboembolism. Agnelli G Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():33-40. PubMed ID: 12073178 [TBL] [Abstract][Full Text] [Related]
23. [Prevention and treatment protocols in thromboembolism]. Martínez Brotons F Rev Esp Cardiol; 1993 Nov; 46(11):688-97. PubMed ID: 8290769 [No Abstract] [Full Text] [Related]
24. Treatment of acute myocardial infarction: in which patients should primary percutaneous transluminal coronary angioplasty be preferred to thrombolysis? Topol EJ Cardiologia; 1996 Sep; 41(9):843-7. PubMed ID: 8940780 [No Abstract] [Full Text] [Related]
27. Conjunctive antithrombotic and thrombolytic therapy for coronary-artery occlusion. Gold HK N Engl J Med; 1990 Nov; 323(21):1483-5. PubMed ID: 2233922 [No Abstract] [Full Text] [Related]
28. [European Society of Cardiology guidelines on ST-elevation myocardial infarction: what is new?]. De Servi S; D'Urbano M G Ital Cardiol (Rome); 2009 Jul; 10(7):490-2. PubMed ID: 19761104 [No Abstract] [Full Text] [Related]
30. Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must? Danchin N Eur Heart J; 2005 Mar; 26(6):529-31. PubMed ID: 15713697 [No Abstract] [Full Text] [Related]
31. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction. Becker RC Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769 [TBL] [Abstract][Full Text] [Related]
33. [Therapy of acute myocardial infarct with thrombolytic drugs. Can use of thrombolytic therapy be further improved?]. Cieslinski G; Klepzig H Fortschr Med; 1993 May; 111(13):209-10, 213. PubMed ID: 8514221 [No Abstract] [Full Text] [Related]
35. [Antithrombotic therapy in the treatment of STEMI and NSTEMI patients]. Nikolić Heitzler V; Pavlov M; Babić Z; Bulj N Acta Med Croatica; 2009 Feb; 63(1):117-9. PubMed ID: 19681476 [TBL] [Abstract][Full Text] [Related]
36. [Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction]. Pereira H Rev Port Cardiol; 2000 Mar; 19(3):379-80. PubMed ID: 10804785 [No Abstract] [Full Text] [Related]
37. [Antithrombotic treatment in connection with PTCA. New substances and regimes are coming]. Scherstén F; Grip L; Emanuelsson H Lakartidningen; 1996 Jun; 93(26-27):2499-502. PubMed ID: 8684080 [No Abstract] [Full Text] [Related]
38. Antithrombotic therapy: the expanding role of low molecular weight heparin. Turpie AG Indian Heart J; 1997; 49(5):489-92. PubMed ID: 9505014 [No Abstract] [Full Text] [Related]
39. Antithrombotic therapy for coronary artery disease and valvular heart disease. Israel DH; Fuster V; Chesebro JH; Badimon L Baillieres Clin Haematol; 1990 Jul; 3(3):705-43. PubMed ID: 2271788 [No Abstract] [Full Text] [Related]
40. A symposium: Thrombosis and antithrombotic therapy--direction for the '90s. April 13-16, 1989, Fort Lauderdale, Florida. Am J Cardiol; 1990 Feb; 65(6):1C-54C. PubMed ID: 2301271 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]